Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Deuterated Compounds. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115745720A enables solvent-free deuteration. Enhances supply chain reliability and reduces manufacturing costs for high-purity deuterated aromatic intermediates.
Patent CN115417782A reveals a green nickel-catalyzed chain walking method for olefin reduction, offering cost-effective pharmaceutical intermediate manufacturing solutions.
Patent CN114835580B reveals metal-free gamma-deuteration method. Enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing with high purity.
Patent CN113354498B enables metal-free deuteration. Enhances supply chain reliability and reduces manufacturing costs for high-purity pharmaceutical intermediates.
Patent CN117603023A reveals metal-free deuteration. Enhances purity and reduces costs for pharmaceutical intermediates manufacturing supply chains.
Advanced preparation method for high-purity deuterated aromatics using polyfluoric anhydride. Cost-effective solution for OLED materials and pharmaceutical intermediates.
Patent CN119118766B reveals hydrophilic carbon catalyst for deuterated intermediates. Enables cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN106565600A enables acid-catalyzed deuteration. High yield, simple conditions. Reliable supply chain partner for pharmaceutical intermediates.
Patent CN108947819A reveals Pd-catalyzed deuteration. High purity over 98 percent, cost-effective solvent system for reliable supply chain.
Novel palladium-catalyzed method enables efficient deuteration without guiding groups, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN117603023B reveals metal-free photocatalytic deuteration. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN110054541B reveals a one-pot Pd-catalyzed method for high-purity deuterated aromatics, offering significant cost reduction and supply chain reliability for pharma intermediates.
Novel metal-free asymmetric deuteration method using D2O. High enantioselectivity for pharma intermediates. Cost-effective supply chain solution.
Patent CN118344244A enables visible light catalyzed deuteration using D2O. Offers cost reduction and scalable supply for high-purity pharmaceutical intermediates.
Patent CN113354498A reveals a metal-free method for reducing aromatic C-N/O/halogen bonds to C-H/D bonds using light induction, offering significant cost reduction in API manufacturing and high-purity deuterated compounds.
Solve explosive risks and metal residues in deuterated synthesis. Achieve 99% deuteration with no catalysts. Scale to 100 MT/annual for drug development.
Struggling with toxic reagents in deuteration? New metal-free methods achieve >95% deuteration. Find reliable suppliers for custom synthesis now.